Insider · CIK 0001666236

Krognes Steve E.

CIK 0001666236 Name as filed on the most recent filing

Filed as Krognes Steve E. (24)

38 transaction lines · from 24 filings · filed 2020-04-01 to 2026-06-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

38 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-04 S, Open-market sale Guardant Health, Inc.GH 1,231,522 disposed Open Form 4 filing 0001666236-26-000018
2025-01-07 S, Open-market sale Denali Therapeutics Inc.DNLI 69,485 disposed Open Form 4 filing 0001714899-25-000048
2024-12-31 S, Open-market sale Denali Therapeutics Inc.DNLI 607,500 disposed Open Form 4 filing 0001714899-25-000002
2024-09-30 S, Open-market sale Denali Therapeutics Inc.DNLI 870,900 disposed Open Form 4 filing 0001714899-24-000200
2024-08-20 S, Open-market sale Denali Therapeutics Inc.DNLI 41,085 disposed Open Form 4 filing 0001714899-24-000196
2024-07-01 S, Open-market sale Denali Therapeutics Inc.DNLI 661,388 disposed Open Form 4 filing 0001714899-24-000156
2024-07-01 S, Open-market sale Denali Therapeutics Inc.DNLI 2,280 disposed Open Form 4 filing 0001714899-24-000156
2024-06-13 S, Open-market sale Denali Therapeutics Inc.DNLI 14,992 disposed Open Form 4 filing 0001714899-24-000156
2024-04-01 S, Open-market sale Denali Therapeutics Inc.DNLI 1,896,250 disposed Open Form 4 filing 0001714899-24-000098
2024-02-13 S, Open-market sale Denali Therapeutics Inc.DNLI 47,548 disposed Open Form 4 filing 0001714899-24-000062
2024-01-05 S, Open-market sale Denali Therapeutics Inc.DNLI 62,331 disposed Open Form 4 filing 0001714899-24-000037
2023-08-21 S, Open-market sale Denali Therapeutics Inc.DNLI 32,069 disposed Open Form 4 filing 0001714899-23-000132
2023-02-13 S, Open-market sale Denali Therapeutics Inc.DNLI 63,782 disposed Open Form 4 filing 0001714899-23-000031
2023-02-08 S, Open-market sale Denali Therapeutics Inc.DNLI 42,522 disposed Open Form 4 filing 0001714899-23-000019
2023-01-05 S, Open-market sale Denali Therapeutics Inc.DNLI 84,467 disposed Open Form 4 filing 0001714899-23-000015
2022-08-19 S, Open-market sale Denali Therapeutics Inc.DNLI 74,845 disposed Open Form 4 filing 0001714899-22-000128
2022-02-11 S, Open-market sale Denali Therapeutics Inc.DNLI 88,806 disposed Open Form 4 filing 0001714899-22-000041
2022-02-09 S, Open-market sale Denali Therapeutics Inc.DNLI 48,073 disposed Open Form 4 filing 0001714899-22-000036
2022-01-05 S, Open-market sale Denali Therapeutics Inc.DNLI 99,569 disposed Open Form 4 filing 0001714899-22-000007
2021-08-19 S, Open-market sale Denali Therapeutics Inc.DNLI 103,249 disposed Open Form 4 filing 0001714899-21-000084
2021-08-19 S, Open-market sale Denali Therapeutics Inc.DNLI 10,014 disposed Open Form 4 filing 0001714899-21-000084
2021-03-15 S, Open-market sale Denali Therapeutics Inc.DNLI 2,005,602 disposed Open Form 4 filing 0001209191-21-021122
2021-03-15 S, Open-market sale Denali Therapeutics Inc.DNLI 810,912 disposed Open Form 4 filing 0001209191-21-021122
2021-03-15 S, Open-market sale Denali Therapeutics Inc.DNLI 204,319 disposed Open Form 4 filing 0001209191-21-021122
2021-03-15 S, Open-market sale Denali Therapeutics Inc.DNLI 73,730 disposed Open Form 4 filing 0001209191-21-021122
2021-02-16 S, Open-market sale Denali Therapeutics Inc.DNLI 1,457,923 disposed Open Form 4 filing 0001209191-21-012052
2021-02-16 S, Open-market sale Denali Therapeutics Inc.DNLI 1,099,996 disposed Open Form 4 filing 0001209191-21-012052
2021-02-16 S, Open-market sale Denali Therapeutics Inc.DNLI 663,323 disposed Open Form 4 filing 0001209191-21-012052
2021-02-16 S, Open-market sale Denali Therapeutics Inc.DNLI 33,468 disposed Open Form 4 filing 0001209191-21-012052
2021-02-11 S, Open-market sale Denali Therapeutics Inc.DNLI 184,908 disposed Open Form 4 filing 0001209191-21-011006
2021-02-11 S, Open-market sale Denali Therapeutics Inc.DNLI 28,571 disposed Open Form 4 filing 0001209191-21-011006
2021-02-09 S, Open-market sale Denali Therapeutics Inc.DNLI 76,018 disposed Open Form 4 filing 0001209191-21-009890
2021-02-09 S, Open-market sale Denali Therapeutics Inc.DNLI 32,116 disposed Open Form 4 filing 0001209191-21-009890
2021-01-15 S, Open-market sale Denali Therapeutics Inc.DNLI 1,037,535 disposed Open Form 4 filing 0001209191-21-004504
2021-01-15 S, Open-market sale Denali Therapeutics Inc.DNLI 1,032,816 disposed Open Form 4 filing 0001209191-21-004504
2021-01-15 S, Open-market sale Denali Therapeutics Inc.DNLI 921,158 disposed Open Form 4 filing 0001209191-21-004504
2021-01-15 S, Open-market sale Denali Therapeutics Inc.DNLI 581,047 disposed Open Form 4 filing 0001209191-21-004504
2020-03-30 S, Open-market sale Denali Therapeutics Inc.DNLI 27,817 disposed Open Form 4 filing 0001209191-20-022241

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 38
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Krognes Steve E., insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001666236

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.